BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 20935265)

  • 1. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells.
    Dong Y; Li L; Wang L; Zhou T; Liu JW; Gao YJ
    Genet Mol Res; 2015 Mar; 14(1):2347-55. PubMed ID: 25867381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
    Yin BB; Wu SJ; Zong HJ; Ma BJ; Cai D
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):256-63. PubMed ID: 21462380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
    Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
    Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
    Huang C; Cao P; Xie Z; Zhu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
    Sahlberg SH; Spiegelberg D; Glimelius B; Stenerlöw B; Nestor M
    PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
    Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
    Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms.
    Wu M; Li T; Chen L; Peng S; Liao W; Bai R; Zhao X; Yang H; Wu C; Zeng H; Liu Y
    J Ethnopharmacol; 2016 Mar; 180():18-27. PubMed ID: 26795076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.